Safeguarding CMMI

CMMI’s broad testing authority results in unchecked ability for the agency to make rapid, broad and unpredictable changes to payment policy. These challenges came to light most recently when CMMI announced proposals for several mandatory payment demonstrations, including the mandatory joint replacement model, the mandatory cardiac demonstration and the Part B drug payment model. All illustrate the consequences for patients, providers and stakeholders. CMMI safeguards are needed so new payment models can be tested and pursued, while protecting quality and patient access to needed care